The purpose of this minor revision was to include consideration for solvent volatility in analytical methods.
The Q3C ICH Guideline was first published in 1997 and provides recommendations on using less toxic solvents in drug substance manufacturing, as well as setting pharmaceutical limits for residual solvents (organic volatile impurities) in drug products.
Source:
ICH: News
Write a comment on this news.